Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study

The Lancet Neurology

Volumn 10, Issue 9, 2011, Pages 785-796

  Murray, Melissa E ^a   Graff Radford, Neill R ^b   Ross, Owen A ^a   Petersen, Ronald C ^c   Duara, Ranjan ^d   Dickson, Dennis W ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COHORT STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; RETROSPECTIVE STUDIES; TAU PROTEINS;

EID: 80051663321     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70156-9     Document Type: Article

References (43)

1. Jack CR, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998, 51:993-999.
2. De Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997, 18:1-11.
3. Desikan RS, Sabuncu MR, Schmansky NJ, et al. Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One 2010, 5:e12853.
4. Frisoni GB, Ganzola R, Canu E, et al. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 2008, 131:3266-3276.
5. Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010, 9:119-128.
6. Giannakopoulos P, Hof PR, Bouras C Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases. Acta Neuropathol 1994, 88:440-447.
7. Braak H, Braak E Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
8. Hyman BT, Trojanowski JQ Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997, 56:1095-1097.
9. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991, 1:103-116.
10. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42:631.
11. Vemuri P, Wiste HJ, Weigand SD, et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 2010, 75:143-151.
12. Hof PR, Bouras C, Constantinidis J, Morrison JH Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res 1989, 493:368-375.
13. Whitwell JL, Jack CR, Przybelski SA, et al. Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 2011, 32:1531-1541.
14. Dickson DW, Crystal H, Mattiace LA, et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989, 78:572-584.
15. Nelson PT, Abner EL, Schmitt FA, et al. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol 2009, 68:774-784.
16. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002, 16:203-212.
17. Folstein MF, Folstein SE, McHugh PR " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
18. Uchikado H, Lin WL, DeLucia MW, Dickson DW Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006, 65:685-697.
19. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002, 61:547-556.
20. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 1987, 46:262-268.
21. Khachaturian ZS Diagnosis of Alzheimer's disease. Arch Neurol 1985, 42:1097-1105.
22. Jellinger KA, Attems J Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol 2003, 105:14-17.
23. Fujishiro H, Ferman TJ, Boeve BF, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008, 67:649-656.
24. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007, 61:435-445.
25. Duvernoy HM The human hippocampus: an atlas of applied anatomy 1988, JF Bergmann, Munich.
26. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999, 8:711-715.
27. Crook R, Hardy J, Duff K Single-day apolipoprotein E genotyping. J Neurosci Methods 1994, 53:125-127.
28. Ross OA, Gosal D, Stone JT, et al. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech Ageing Dev 2007, 128:378-382.
29. Zabetian CP, Hutter CM, Factor SA, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007, 62:137-144.
30. van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE e{open}4 allele. Lancet Neurol 2011, 10:280-288.
31. Craig-Schapiro R, Fagan AM, Holtzman DM Biomarkers of Alzheimer's disease. Neurobiol Dis 2009, 35:128-140.
32. Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (≥80 years of age) humans. Acta Neuropathol 1994, 88:212-221.
33. Nelson PT, Schmitt FA, Lin Y, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011, 134:1506-1518.
34. Arai T, Mackenzie IR, Hasegawa M, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009, 117:125-136.
35. Josephs KA, Whitwell JL, Knopman DS, et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 2008, 70:1850-1857.
36. Iseki E, Yamamoto R, Murayama N, et al. Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia. Neurosci Lett 2006, 405:29-33.
37. Jellinger KA, Attems J Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol 2007, 113:107-117.
38. Jellinger KA, Bancher C Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol 1998, 8:367-376.
39. Braak H, Braak E Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol 1990, 80:479-486.
40. Bancher C, Egensperger R, Kosel S, Jellinger K, Graeber MB Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 1997, 94:403-409.
41. Kril J, Patel S, Harding A, Halliday G Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol 2002, 103:370-376.
42. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004, 63:1168-1174.
43. Uchihara T, Nakamura A, Yamazaki M, Mori O Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 2001, 101:535-539.